{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:13:39Z","timestamp":1791198819353,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.critrevonc.2008.12.003","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T09:43:25Z","timestamp":1233222205000},"page":"1-9","source":"Crossref","is-referenced-by-count":51,"title":["Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model"],"prefix":"10.1016","volume":"72","author":[{"given":"Anis","family":"Feki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Bellingan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Petignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazib","family":"Pervaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmgard","family":"Irminger-Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.12.003_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0959-8049(01)00350-1","article-title":"Estimates of cancer incidence and mortality in Europe in 1995","volume":"38","author":"Bray","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/cncr.9048","article-title":"Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens","volume":"93","author":"Chhieng","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib4","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1023791229361","article-title":"Intraperitoneal cancer dissemination: mechanisms of the patterns of spread","volume":"22","author":"Carmignani","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib6","series-title":"Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology","author":"Ph","year":"1995"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10937400701876095","article-title":"Risk factors for ovarian cancer: an overview with emphasis on hormonal factors","volume":"11","author":"Salehi","year":"2008","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.22.2.255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ncponc0342","article-title":"Angiogenic inhibitors: a new therapeutic strategy in oncology","volume":"2","author":"Gasparini","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib11","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Burger","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib15","first-page":"1673","article-title":"Diagnosing ascitic etiology on a biochemical basis","volume":"45","author":"Bansal","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hep.1840080521","article-title":"Ascitic fluid analysis in malignancy-related ascites","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7","article-title":"Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease","volume":"85","author":"Kraft","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib18","first-page":"445","article-title":"Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases","volume":"16","author":"Xu","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization","volume":"153","author":"Mesiano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib20","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0002-9440(10)64467-7","article-title":"Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer","volume":"161","author":"Hu","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib21","first-page":"126","article-title":"Ovarian cancer screening","volume":"36","author":"Neesham","year":"2007","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib22","first-page":"91","article-title":"Prevention and early detection of ovarian cancer: mission impossible? Recent Results","volume":"174","author":"Bast","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2007.09.014","article-title":"Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?","volume":"108","author":"Ayhan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-8-31","article-title":"The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study","volume":"8","author":"Tetsche","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/COC.0b013e318134ee6f","article-title":"For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?","volume":"31","author":"Dizon","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib28","first-page":"283","article-title":"Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens","volume":"13","author":"Fu","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib29","first-page":"1108","article-title":"In vivo and in vitro studies of experimental ovarian adenocarcinoma in rats","volume":"39","author":"Sekiya","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0090-8258(89)90109-1","article-title":"Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatin","volume":"34","author":"Pretorius","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib31","first-page":"1997","article-title":"6-[18F]fluoro-L-fucose: a possible tracer for assessing glycoconjugate synthesis in tumors with positron emission tomography","volume":"31","author":"Ishiwata","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/ob.1996.v175.a73595","article-title":"Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat","volume":"175","author":"Rose","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib33","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.4049\/jimmunol.157.6.2577","article-title":"In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes","volume":"157","author":"Bellingan","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib34","first-page":"585","article-title":"The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and reticulum cells","volume":"28","author":"Beelen","year":"1980","journal-title":"J Reticuloendothel Soc"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib35","first-page":"2778","article-title":"Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity","volume":"54","author":"Testa","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib36","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.critrevonc.2008.12.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1998.1","article-title":"United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia","volume":"77","author":"Workman","year":"1998","journal-title":"Br J Cancer (second edition)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808003028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:08:01Z","timestamp":1684872481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1040842808003028"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.12.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}